Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, a mixture of very long chain saturated fatty acids

Pharmacological Research

Volumn 44, Issue 4, 2001, Pages 299-304

  Menéndez, Roberto ^a   Más, Rosa ^a   Amor, Ana María ^a   Rodeiros, Idania ^a   MarÍa Gonzalez, Rosa ^a   Alfonso, José Luis ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

Cholesterol biosynthesis; Cultured fibroblasts; D003; HMG CoA reductase; Very long chain saturated fatty acids

Indexed keywords

ACETIC ACID; CARBON 14; CHOLESTEROL; D 0003; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; MEVALONIC ACID; NATURAL PRODUCT; SATURATED FATTY ACID; TRITIUM; VERY LONG CHAIN FATTY ACID; WATER;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOSYNTHESIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; EMULSION; ENZYME ACTIVITY; FIBROBLAST CULTURE; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL;

EID: 0034774858     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0851     Document Type: Article

References (45)

1. A receptor-mediated pathway for cholesterol homeostasis
2. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity
3. Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanism
4. HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
5. Inhibition of cholesterol synthesis
6. Regulation of hepatic HMG-CoA reductase
7. Multivalent feedback regulation of HMG-CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth
8. The discovery and development of HMG-CoA reductase inhibitors
9. Cholesterol-lowering effects of policosanol on normocholesterolemic rabbits
10. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolemia induced by a wheat starch-casein diet
11. Effect of policosanol chronically administered in male monkeys (Macaea arctoides)
12. Effects of policosanol on serum lipids and lipoprotein in healthy volunteers
13. Effects of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemia
14. Eficacia, seguridad y tolerabilidad del policosanol en pacientes argentinos con hipercolesterolemia tipo II, Estudio Abierto
15. One-year study on the effect of policosanol(5 mg-twice-a-day) on lipid profile in patients with type II hypercholesterolemia
16. Effect of policosanol on primary hypercholesterolemia: A one-year open follow-up
17. A double-blind placebo-controlled study of the effect of policosanol in patients with intermittent claudication
18. A long-term open study of the efficacy and tolerability of policosanol in patients with high global coronary risk
19. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
20. Policosanol inhibits cholesterol biosynthesis and enhances LDL processing in cultured fibroblasts
21. Biodistribution and metabolism of orally administered octacosanol in rats
22. 14C)-octacosanol in liver and muscle of rats after serial administration
23. Metabolism of octacosanol in liver and muscle of rats
24. Fatty alcohol metabolism in cultured fibroblasts. Evidence for a fatty alcohol cycle
25. Sjögre-Laarsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine nucleotide oxidore-ductase activity
26. Very long chain fatty acid β-oxidation by rat liver mitochondria and peroxisomes
27. A comparative study of stearic acid and lignoceric acid oxidation by human skin fibroblasts
28. Studies of peroxisomal oxidation of palmitate and lignocerate in rat liver
29. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
30. Measurement of rates of cholesterol synthesis using tritiated water
31. The effect of (-)-hydroxycitrate on the activity of the low-density lipoprotein receptor and 3-hydroxy-3-methyl glutaryl coenzyme. A reductase levels in the human hepatoma cell line Hep G2
32. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A activity and inhibition of growth of human fibroblasts by 7-ketocholesterol
33. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A in cultured fibroblasts
34. Regulation of mevalonate pathway
35. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
36. Regulation of gene expression and synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by micellar cholesterol in Caco-2 cells
37. Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by low-density lipoprotein and 25-hydroxycholesterol in UT-1 cells
38. Mevanolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes
39. +-ATPase activity in Saccharomyse cerevisae caused by decanoic acid
40. In vitro modulation of rat adipocyte ghost membrane fluidity by cholesterol oxysterols
41. Effects of long-chain saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro
42. The effect of phosphatidylcholine to sphingomyelin mole ratio on the dynamic properties of sheep erythrocyte membrane
43. Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by changes in microsomal cholesterol content or phospholipid composition